Author:
Evans Rebecca E.,Peterson Jennifer,Kim Jon Jin,Mahaveer Ajit
Abstract
Due to a plethora of risk factors, including prematurity, neonates are at risk for acute kidney injury (AKI) and, once established, AKI is associated with poor outcomes. The most widely used AKI biomarker is creatinine, despite research demonstrating creatinine to be a suboptimal tool for diagnosing neonatal AKI. This article uses an amalgamated case study to illustrate the inadequacies of creatinine for detection of preterm AKI and to present a range of novel AKI biomarkers relevant to the neonatal population. Clinical evaluation of novel AKI biomarkers is needed to improve precision and rapidity of AKI management in neonates.
Subject
Pediatrics, Perinatology and Child Health
Reference42 articles.
1. Human intrauterine renal growth expressed in absolute number of glomeruli assessed by the disector method and cavalieri principle;Hinchliffe;Lab Invest,1991
2. The impacy of kidney development on the life course: a consensus document for action;Nephron,2017
3. Nephrotoxic medication exposure in very low birth weight infants;Rhone;J Matern Foetal Neonatal Med,2014
4. Acute kidney injury in neonates: from urine output to new biomarkers;Libório;BioMed Res Int,2014
5. Neonatal acute kidney injury;Selewski;Paediatrics,2015